APSIC GUIDELINES for the prevention of SSI.  

December 13, 2019 at 7:15 am

Antimicrob Resist Infect Control. November 12, 2019 V.8 P.174.

Ling ML, Apisarnthanarak A, Abbas A, et al.

Background

The Asia Pacific Society of Infection Control (APSIC) launched the APSIC Guidelines for the Prevention of Surgical Site Infections in 2018. This document describes the guidelines and recommendations for the setting prevention of surgical site infections (SSIs). It aims to highlight practical recommendations in a concise format designed to assist healthcare facilities at Asia Pacific region in achieving high standards in preoperative, perioperative and postoperative practices.

Method

The guidelines were developed by an appointed workgroup comprising experts in the Asia Pacific region, following reviews of previously published guidelines and recommendations relevant to each section.

Results

It recommends that healthcare facilities review specific risk factors and develop effective prevention strategies, which would be cost effective at local levels. Gaps identified are best closed using a quality improvement process. Surveillance of SSIs is recommended using accepted international methodology. The timely feedback of the data analysed would help in the monitoring of effective implementation of interventions.

Conclusions

Healthcare facilities should aim for excellence in safe surgery practices. The implementation of evidence-based practices using a quality improvement process helps towards achieving effective and sustainable results.

PDF

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852795/pdf/13756_2019_Article_638.pdf

Entry filed under: CONSENSOS, Desinfection and Sterilization, Epidemiología, FIEBRE en el POSTOPERATORIO, GUIDELINES, Health Care-Associated Infections, Infecciones asociadas a catater IV, Infecciones nosocomiales, Infecciones sitio quirurgico, Metodos diagnosticos, Prevencion y Control de Infecciones, Profilaxis Antibiótica en Cirugía - PAC, Update.

Changes in Body Mass Index and Atherosclerotic Disease Risk Score After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide. Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥ 65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices.


Calendar

December 2019
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Most Recent Posts


%d bloggers like this: